Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.99
- Piotroski Score 4.00
- Grade Buy
- Symbol (ANGO)
- Company AngioDynamics, Inc.
- Price $7.20
- Changes Percentage (0.63%)
- Change $0.05
- Day Low $7.04
- Day High $7.30
- Year High $8.25
AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 01/02/2025
- Fiscal Year End N/A
- Average Stock Price Target $13.00
- High Stock Price Target $22.00
- Low Stock Price Target $12.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$4.80
- Trailing P/E Ratio -1.3
- Forward P/E Ratio -1.3
- P/E Growth -1.3
- Net Income $-184,349,000
Income Statement
Quarterly
Annual
Latest News of ANGO
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Roblox Will Ban Kids Under 13 From 'Social Hangouts'
Roblox Corp. has implemented new rules to enhance child safety, preventing kids under 13 from accessing certain online games and features. The company aims to create a safer environment for its young ...
By Yahoo! Finance | 1 day ago -
Cango Inc (CANG) Q3 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ...
Cango's CEO, Lin Jiayuan, anticipates a positive impact from China's economic recovery on the company's business. They ensure used car quality through extensive inspections and customer feedback handl...
By Yahoo! Finance | 2 days ago -
Annarella and Django: Jouer review - flute and west African lute shine in expressive new partnership
The combination of flute and ngoni in the album "We Are Busy Bodies" shines best when the full-band accompaniment is stripped back, highlighting the duo's artistry and chemistry. The gentle yet pervas...
By The Guardian | 1 week ago
